Trademark Filing

The mark consists of a ribbon design.

Mark For: This trademark registration is intended to cover the categories of pharmaceutical preparations for the treatment of psychiatric and neurodegenerative diseases and disorders including schizophrenia, depression, major depressive disorder, stress, anxiety, treatment resistant depression, bipolar depression, bipolar disorder; pharmaceutical preparations for the mitigation of weight gain and the treatment of metabolic diseases and dyslipidemia. [all]

>Color is not claimed as a feature of the mark. The mark consists of a ribbon design.

Status

2020-05-09 UTC
⟳ Refresh

LIVE APPLICATION Under Examination

Research	OneLook Acronym Finder
Serial Number	88420585
Registration Number	6687304
Mark Literal Elements	None
Mark Drawing Type	2 - AN ILLUSTRATION DRAWING WITHOUT ANY WORDS(S)/ LETTER(S)/NUMBER(S)
Mark Type	TRADEMARK
Standard Character Claim	No
Register	PRINCIPAL
Current Location	INTENT TO USE SECTION 2019-10-01
Basis	1(b)
Class Status	ACTIVE
Primary US Classes	006: Chemicals and Chemical Compositions 018: Medicines and Pharmaceutical Preparations 044: Dental, Medical and Surgical Appliances 046: Foods and Ingredients of Foods 051: Cosmetics and Toilet Preparations 052: Detergents and Soaps
Primary International Class	005 - Primary Class (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed Use	No
Current Use	No
Intent To Use	Yes
Filed ITU	Yes
44D Filed	No
44E Current	No
66A Current	No
Current Basis	No
No Basis	No
Domestic Representative	Norm J. Rich
Attorney Name	Norm J. Rich
Attorney Docket Number	029318-2808
Law Office Assigned	L60
Employee Name	KON, ELISSA GARBER

Timeline

Click the blue "Refresh" button to load certificates, specimines, application, and other documents.

IC 005. US 006 018 044 046 051 052. G & S: Pharmaceutical preparations for the treatment of psychiatric and neurodegenerative diseases and disorders including schizophrenia, depression, major depressive disorder, stress, anxiety, treatment resistant depression, bipolar depression, bipolar disorder; pharmaceutical preparations for the mitigation of weight gain and the treatment of metabolic diseases and dyslipidemia